drugset / Trial / NCT02227927

Treatment Use of Domperidone for Gastroparesis

NCT02227927

Expanded access No longer available Scott Gabbard, MD

Summary

Domperidone is a drug that may be of benefit to individuals with gastroesophageal reflux disease (GERD), with upper GI symptoms, gastroparesis, and chronic constipation. This is a long-term treatment program for prescription of this drug to all patients who, in the investigators' judgement, could benefit from its use.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Domperidone Unknown 10 mg Oral
Subject Domperidone Unknown 30 mg Oral